These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24941049)

  • 21. Pharmacogenetics of HIV therapy.
    Owen A; Pirmohamed M; Khoo SH; Back DJ
    Pharmacogenet Genomics; 2006 Oct; 16(10):693-703. PubMed ID: 17001288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiretroviral use during pregnancy for treatment or prophylaxis.
    Sturt AS; Read JS
    Expert Opin Pharmacother; 2011 Aug; 12(12):1875-85. PubMed ID: 21534886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic Polymorphisms Affecting the Pharmacokinetics of Antiretroviral Drugs.
    Calcagno A; Cusato J; D'Avolio A; Bonora S
    Clin Pharmacokinet; 2017 Apr; 56(4):355-369. PubMed ID: 27641153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Individualization of antiretroviral therapy--pharmacogenomic aspect.
    Dalal B; Shankarkumar A; Ghosh K
    Indian J Med Res; 2015 Dec; 142(6):663-74. PubMed ID: 26831415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dyslipidemia in HIV-infected individuals: from pharmacogenetics to pharmacogenomics.
    Tarr PE; Rotger M; Telenti A
    Pharmacogenomics; 2010 Apr; 11(4):587-94. PubMed ID: 20350140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the pharmacogenetics of immune recovery in treated HIV-infected patients.
    Peraire J; Viladés C; Pacheco YM; López-Dupla M; Domingo P; Gutiérrez M; Rosado I; Leal M; Richart C; Vidal F
    Expert Opin Drug Metab Toxicol; 2014 Jan; 10(1):81-101. PubMed ID: 24256435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of genomics on the path to personalized medicine.
    Tremblay J; Hamet P
    Metabolism; 2013 Jan; 62 Suppl 1():S2-5. PubMed ID: 23021037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management and treatment of chronic hepatitis C in HIV patients.
    Barreiro P; Vispo E; Labarga P; Soriano V
    Semin Liver Dis; 2012 May; 32(2):138-46. PubMed ID: 22760653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abacavir and lamivudine for the treatment of human immunodeficiency virus.
    Rizzardini G; Zucchi P
    Expert Opin Pharmacother; 2011 Sep; 12(13):2129-38. PubMed ID: 21787242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiretroviral drug-related toxicities - clinical spectrum, prevention, and management.
    Fernandez-Montero JV; Eugenia E; Barreiro P; Labarga P; Soriano V
    Expert Opin Drug Saf; 2013 Sep; 12(5):697-707. PubMed ID: 23730950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pharmacogenetics of antiretroviral therapy: a review of studies to date.
    Quirk E; McLeod H; Powderly W
    Clin Infect Dis; 2004 Jul; 39(1):98-106. PubMed ID: 15206060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time (again) for a randomized trial of pharmacogenetics of antiretroviral therapy.
    Telenti A
    Pharmacogenomics; 2009 Apr; 10(4):515-6. PubMed ID: 19374508
    [No Abstract]   [Full Text] [Related]  

  • 33. The clinical implications of antiretroviral pharmacogenomics.
    Fox J; Boffito M; Winston A
    Pharmacogenomics; 2006 Jun; 7(4):587-96. PubMed ID: 16753006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacogenetics of adverse effects due to antiretroviral drugs.
    Vidal F; Gutiérrez F; Gutiérrez M; Olona M; Sánchez V; Mateo G; Peraire J; Viladés C; Veloso S; López-Dupla M; Domingo P
    AIDS Rev; 2010; 12(1):15-30. PubMed ID: 20216907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The evolution of three decades of antiretroviral therapy: challenges, triumphs and the promise of the future.
    Tseng A; Seet J; Phillips EJ
    Br J Clin Pharmacol; 2015 Feb; 79(2):182-94. PubMed ID: 24730660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An update on ethnic differences in drug metabolism and toxicity from anti-cancer drugs.
    Phan VH; Tan C; Rittau A; Xu H; McLachlan AJ; Clarke SJ
    Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1395-410. PubMed ID: 21950349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in HIV pharmacology: protein binding, pharmacogenomics, and therapeutic drug monitoring.
    Flexner CW
    Top HIV Med; 2003; 11(2):40-4. PubMed ID: 12717040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV pharmacogenetics in clinical practice: recent achievements and future challenges.
    Tozzi V; Libertone R; Liuzzi G
    Curr HIV Res; 2008 Nov; 6(6):544-54. PubMed ID: 18991620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of formulation on the pharmacokinetics of antiretroviral drugs.
    Bastiaans DE; Cressey TR; Vromans H; Burger DM
    Expert Opin Drug Metab Toxicol; 2014 Jul; 10(7):1019-37. PubMed ID: 24877605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenetics of tenofovir treatment.
    Rodriguez-Novoa S; Labarga P; Soriano V
    Pharmacogenomics; 2009 Oct; 10(10):1675-85. PubMed ID: 19842939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.